Aclaris Therapeutics Stock Volatility
| ACRS Stock | USD 1.22 0.02 1.61% |
We consider Aclaris Therapeutics slightly risky. Aclaris Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0054, which signifies that the company had a 0.0054% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Aclaris Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Aclaris Therapeutics' Risk Adjusted Performance of 0.0318, mean deviation of 2.75, and Downside Deviation of 3.88 to double-check if the risk estimate we provide is consistent with the expected return of 0.0207%. Key indicators related to Aclaris Therapeutics' volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Aclaris Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Aclaris daily returns, and it is calculated using variance and standard deviation. We also use Aclaris's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Aclaris Therapeutics volatility.
Aclaris |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Aclaris Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Aclaris Therapeutics at lower prices. For example, an investor can purchase Aclaris stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Aclaris Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Aclaris Therapeutics Market Sensitivity And Downside Risk
Aclaris Therapeutics' beta coefficient measures the volatility of Aclaris stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Aclaris stock's returns against your selected market. In other words, Aclaris Therapeutics's beta of 1.97 provides an investor with an approximation of how much risk Aclaris Therapeutics stock can potentially add to one of your existing portfolios. Aclaris Therapeutics shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Aclaris Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Aclaris Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Aclaris Therapeutics Demand TrendCheck current 90 days Aclaris Therapeutics correlation with market (NYSE Composite)Aclaris Beta |
Aclaris standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 3.83 |
It is essential to understand the difference between upside risk (as represented by Aclaris Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Aclaris Therapeutics' daily returns or price. Since the actual investment returns on holding a position in aclaris stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Aclaris Therapeutics.
Using Aclaris Put Option to Manage Risk
Put options written on Aclaris Therapeutics grant holders of the option the right to sell a specified amount of Aclaris Therapeutics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Aclaris Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Aclaris Therapeutics' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Aclaris Therapeutics will be realized, the loss incurred will be offset by the profits made with the option trade.
Aclaris Therapeutics' PUT expiring on 2024-05-17
Profit |
| Aclaris Therapeutics Price At Expiration |
Current Aclaris Therapeutics Insurance Chain
| Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Put | 2024-05-17 PUT at $2.0 | -0.4966 | 0.3276 | 7 | 2024-05-17 | 0.65 - 1.45 | 1.0 | View |
Put | 2024-05-17 PUT at $1.5 | -0.7362 | 1.0646 | 356 | 2024-05-17 | 0.25 - 0.35 | 0.35 | View |
Put | 2024-05-17 PUT at $1.0 | -0.1971 | 0.7122 | 505 | 2024-05-17 | 0.0 - 0.05 | 0.05 | View |
Aclaris Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Aclaris Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Aclaris Therapeutics' price changes. Investors will then calculate the volatility of Aclaris Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Aclaris Therapeutics' volatility:
Historical Volatility
This type of stock volatility measures Aclaris Therapeutics' fluctuations based on previous trends. It's commonly used to predict Aclaris Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Aclaris Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Aclaris Therapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Aclaris Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Aclaris Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 1.9712 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Aclaris Therapeutics will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aclaris Therapeutics or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aclaris Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aclaris stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Aclaris Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Predicted Return Density |
| Returns |
What Drives an Aclaris Therapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Aclaris Therapeutics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Aclaris Therapeutics is 18467.14. The daily returns are distributed with a variance of 14.65 and standard deviation of 3.83. The mean deviation of Aclaris Therapeutics is currently at 2.62. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.61
α | Alpha over NYSE Composite | -0.0066 | |
β | Beta against NYSE Composite | 1.97 | |
σ | Overall volatility | 3.83 | |
Ir | Information ratio | 0.02 |
Aclaris Therapeutics Stock Return Volatility
Aclaris Therapeutics historical daily return volatility represents how much of Aclaris Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 3.828% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.6252% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Aclaris Therapeutics Volatility
Volatility is a rate at which the price of Aclaris Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Aclaris Therapeutics may increase or decrease. In other words, similar to Aclaris's beta indicator, it measures the risk of Aclaris Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Aclaris Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 254.7 K | 242 K | |
| Market Cap | 84.3 M | 80.1 M |
Aclaris Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Aclaris Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Aclaris Therapeutics' price varies over time.
3 ways to utilize Aclaris Therapeutics' volatility to invest better
Higher Aclaris Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Aclaris Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Aclaris Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Aclaris Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Aclaris Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Aclaris Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Aclaris Therapeutics Investment Opportunity
Aclaris Therapeutics has a volatility of 3.83 and is 6.08 times more volatile than NYSE Composite. Compared to the overall equity markets, volatility of historical daily returns of Aclaris Therapeutics is lower than 33 percent of all global equities and portfolios over the last 90 days. You can use Aclaris Therapeutics to protect your portfolios against small market fluctuations. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Aclaris Therapeutics to be traded at $1.1834 in 90 days.Weak diversification
The correlation between Aclaris Therapeutics and NYA is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and NYA in the same portfolio, assuming nothing else is changed.
Aclaris Therapeutics Additional Risk Indicators
The analysis of Aclaris Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Aclaris Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Aclaris Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0318 | |||
| Market Risk Adjusted Performance | 0.082 | |||
| Mean Deviation | 2.75 | |||
| Semi Deviation | 3.34 | |||
| Downside Deviation | 3.88 | |||
| Coefficient Of Variation | 2621.86 | |||
| Standard Deviation | 3.98 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Aclaris Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Aclaris Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Aclaris Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Aclaris Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Aclaris Therapeutics.
When determining whether Aclaris Therapeutics is a strong investment it is important to analyze Aclaris Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclaris Therapeutics' future performance. For an informed investment choice regarding Aclaris Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclaris Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Aclaris Stock analysis
When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Aclaris Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclaris Therapeutics. If investors know Aclaris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclaris Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.27) | Revenue Per Share 0.448 | Quarterly Revenue Growth 1.266 | Return On Assets (0.33) | Return On Equity (0.50) |
The market value of Aclaris Therapeutics is measured differently than its book value, which is the value of Aclaris that is recorded on the company's balance sheet. Investors also form their own opinion of Aclaris Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aclaris Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclaris Therapeutics' market value can be influenced by many factors that don't directly affect Aclaris Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclaris Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclaris Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclaris Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.